Advanced Search

    Technical Analysis for PHGUF - Pharming Grp Nv Leid

    Grade Last Price % Change Price Change
    B 1.2000 -2.60% -0.0320
    PHGUF closed down 2.6 percent on Wednesday, June 7, 2023, on 32 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical PHGUF trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Crossed Above 50 DMA Bullish -2.60%
    MACD Bullish Centerline Cross Bullish -2.60%
    MACD Bullish Signal Line Cross Bullish -2.60%
    Pocket Pivot Bullish Swing Setup -2.60%
    Volume Surge Other -2.60%
    Narrow Range Bar Range Contraction -2.60%
    Older End-of-Day Signals for PHGUF ...

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    PHGUF Chart by TradingView
    Basic chart:

    Profile

    Pharming Grp Nv Leid Description

    Pharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company’s products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming’s technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company’s commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Recombinant Biopharmaceuticals Molecular Biology Genetic Engineering Recombinant Proteins Biological Engineering Bleeding Recombinant Dna

    Is PHGUF a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 18 Pharming Group Full Year 2022 Earnings: EPS: US$0.021 (vs US$0.025 in FY 2021)
    Mar 14 Why Earnings Season Could Be Great for Pharming Group (PHAR)
    Mar 13 Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank Limited in light of UK Government announcement
    Mar 13 Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement
    Mar 12 Dutch biotech Pharming says it held $45 mln in collapsed SVB
    Mar 12 Pharming Group issues statement regarding the events surrounding Silicon Valley Bank
    Feb 28 Notice of Full Year 2022 financial results
    Feb 16 Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe
    Dec 19 Pharming Group N.V.'s (AMS:PHARM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
    Dec 15 Pharming Highlights Interim Data From Rare Immune Deficiency Study
    See more PHGUF news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.85
    52 Week Low 0.735
    Average Volume 3,173
    200-Day Moving Average 1.1414
    50-Day Moving Average 1.2092
    20-Day Moving Average 1.1955
    10-Day Moving Average 1.1860
    Average True Range 0.0731
    RSI (14) 49.75
    ADX 21.66
    +DI 51.8685
    -DI 36.0106
    Chandelier Exit (Long, 3 ATRs) 1.3707
    Chandelier Exit (Short, 3 ATRs) 1.1793
    Upper Bollinger Bands 1.4025
    Lower Bollinger Band 0.9885
    Percent B (%b) 0.51
    BandWidth 34.6299
    MACD Line 0.0006
    MACD Signal Line 0.0009
    MACD Histogram -0.0003
    Fundamentals Value
    Market Cap 765.67 Million
    Num Shares 638 Million
    EPS -0.06
    Price-to-Earnings (P/E) Ratio -20.00
    Price-to-Sales 4.63
    Price-to-Book 5.43
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.2000
    Resistance 3 (R3) 1.2000 1.2000 1.2000
    Resistance 2 (R2) 1.2000 1.2000 1.2000 1.2000
    Resistance 1 (R1) 1.2000 1.2000 1.2000 1.2000 1.2000
    Pivot Point 1.2000 1.2000 1.2000 1.2000 1.2000
    Support 1 (S1) 1.2000 1.2000 1.2000 1.2000 1.2000
    Support 2 (S2) 1.2000 1.2000 1.2000 1.2000
    Support 3 (S3) 1.2000 1.2000 1.2000
    Support 4 (S4) 1.2000